EMERGENT BIOSOLUTIONS INC. Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)

Item 2.02 Results of Operations and Financial Condition.

On August 01, 2022, Emergent BioSolutions Inc. (the "Company") announced financial and operating results for the period ended June 30, 2022. The Company will also use presentation materials in connection with its first quarter conference call ("Earnings Call Slides"), which will be posted on the Company's website at www.emergentbiosolutions.com. Copies of the press release and Earnings Call Slides are furnished as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K, respectively, and are incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

The disclosure contained in Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                               Description
99.1                          Earnings press release issued by the Company on August 01, 2022.
99.2                          Earnings Call Slides, dated August 01, 2022.
                            Emergent BioSolutions Inc. Current Report on Form 8-K/A, dated August
                            02, 2022 formatted in XBRL (Extensible Business Reporting Language):
101                         Cover Page. The instance document does not appear in the Interactive
                            Data File because its XBRL tags are embedded within the Inline XBRL
                            document.
                            Cover Page Interactive Data File (formatted as Inline XBRL and contained
104                         in Exhibit 101).

© Edgar Online, source Glimpses